维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

19篇 您的检索式：作者名="CHRISTAKOU C"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	PCOS: the commonest cause of hyperandrogenemiain women as a risk factor for metabolic syndrome 显示文摘	Diamanti K E Christakou C Kandarakis H	2007	Minerva Endocrinol2007，32，1：	1
	2	Vitamin-D-dependent calcium-binding proteins:chemistry,distribution, functional considerations and molecular biology显示文摘	Christakes S Gabrielids C Rhoten W B	1989	Endoc Rev1989，，10：	1
	3	Phenotypes and enviromental factors: their influence in PCOS显示文摘	Diamanti-Kandarakis E Christakou C Marinakis E	2012	Curr Pharm Des2012，18，3：	1
	4	Polycystic ovarian syndrome:the commonest cause of hyperandrogenemia in women as a risk factor for metabolic syndrome显示文摘	Diamanti-Kandarakis E Christakou C Kandarakis H	2007	Minerva Endocrinol2007，32，1：	1
	5	Phenotypes and environmental factors:their influence in PCOS 显示文摘	Diamanti-Kandarakis E Christakou C Marinakis E	2012	Curr Pharm Des2012，18，3：	1
	6	Polycystic ovarian syndrome: the commonest cause of hyperandrogenemia in women as a risk factor for metabolic syndrome 显示文摘	Diamanti-Kandarakis E Christakou C Kandarakis H	2007	Minerva Endocrinol2007，32，1：	1
	7	Does polycystic ovary syndrome start in childhood?显示文摘	Diamanti-Kandarakis E Christakou C Palioura E	2008	Pediatr Endocrinol Rev2008，5，：	1
	8	The benefit-to-risk ratio of common treatments in PCOS:effect of oral contraceptives versus metformin on atherogenic markers显示文摘	Christakou C Kollias A Piperi C	2014	Hormones (Athens)2014，13，4：	1
	9	The benefit-to-risk ratio of common treatments in PCOS: effect of oral contraceptives versus metformin on atherogenic markers显示文摘	CHRISTAKOU C KOLLIAS A PIPERI C	2015	Hormones2015，13，4：	1
	10	Prevalence,defini-tion and clinical manifestations of polycystic ovarian syn-drome显示文摘	Diamanti-Kandarakis E Christakou C	2006	Endocrinol Nutr2006，53，1：	1
	11	Polycysticovarian syndrome ; the commonest cause of hyperandrogenemia inwomen as a risk factor for metabolic syndrome 显示文摘	Diamanti - Kandarakis E Christakou C Kandarakis H	2007	Minerva Endo-crinol2007，32，1：	1
	12	A hybrid movie recommender system based on neural networks显示文摘	CHRISTAKOU C VRETTOS S STAFYLOPATIS A	2007	Interna tional Journal on Artificial Intelligence Tools2007，16，5：	1
	13	Prevalence, denition and clinical manifestations of polycystic ovary syndrome 显示文摘	Diamanti - Kandarakis E Christakou C	2006	Endocrinol Nutr2006，53，1：	1
	14	Metabolic syndrome and polycystic ovary syndrome:, and vice versa显示文摘	Kandaraki E Christakou C Diamanti-Kandarakis E	2009	Arq Bras Endocrinol Metabol2009，53，2：	1
	15	Prevalence, definition and clinical manifestations of polycystic ovary syndrome显示文摘	Diamanti-Kandarakis E Christakou C	2006	Endocrinol Nutr2006，53，1：	1
	16	Polycystic ovarian syndrome:the commonest cause of hyperandrogenemia in women as a risk factor for metabolic syrdrome显示文摘	Diamanti - Kandarakis E Christakou C Kandarakis H	2007	Minerva Endocrinol2007，32，1：	1
	17	Does poly- cystic ovary syndrome start in childhood? 显示文摘	Diamanti - Kandarakis E Christakou C Palioura E	2008	Pediatr Endocrinol Rev2008，5，4：	1
	18	Polycystic ovarian syndrome: the commonest cause of hyperandrogenemia in women as a risk factor for metabolic syndrome显示文摘	Diamanti K E Christakou C Kandarakis H A	2007	Minerva Endocrinol2007，32，：	1
	19	Does poly- cystic ovary syndrome start in childhood? 显示文摘	Diamanti-Kandarakis E Christakou C Palioura E	2008	Pediatr Endocrinol Rev2008，5，4：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费